NCT07745361 Study of Oral MRT-2359 With Apalutamide in Prostate Cancer Status RECRUITING Phase PHASE2
NCT07658573 AI Multimodal Model for Predicting CRPC Progression Risk Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07641855 A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT07503808 A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types Status RECRUITING Phase PHASE1
NCT06966024 Study of DCC-2812 in Participants With Advanced Genitourinary Cancers Status RECRUITING Phase PHASE1
NCT06895811 Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06378866 Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial Status RECRUITING Phase PHASE2
NCT06228404 Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05502315 Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04549207 Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04090528 pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03652493 Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway Status COMPLETED Phase PHASE2